Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.66 CNY -0.91%
Market Cap: 101.3B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note

Shanghai RAAS Blood Products Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai RAAS Blood Products Co Ltd
Cash from Investing Activities Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Investing Activities
-ÂĄ1.2B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
-30%
Beigene Ltd
HKEX:6160
Cash from Investing Activities
ÂĄ117.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Investing Activities
-ÂĄ998.7m
CAGR 3-Years
39%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Investing Activities
-ÂĄ2.1B
CAGR 3-Years
-91%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Investing Activities
-ÂĄ837.9m
CAGR 3-Years
21%
CAGR 5-Years
-18%
CAGR 10-Years
-12%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Investing Activities
-ÂĄ1.3B
CAGR 3-Years
-12%
CAGR 5-Years
-102%
CAGR 10-Years
N/A

See Also

What is Shanghai RAAS Blood Products Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.2B CNY

Based on the financial report for Jun 30, 2024, Shanghai RAAS Blood Products Co Ltd's Cash from Investing Activities amounts to -1.2B CNY.

What is Shanghai RAAS Blood Products Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-30%

Over the last year, the Cash from Investing Activities growth was 15%. The average annual Cash from Investing Activities growth rates for Shanghai RAAS Blood Products Co Ltd have been -24% over the past three years , and -30% over the past ten years .

Back to Top